**Core Concept**
Myasthenia gravis (MG) is an autoimmune disorder characterized by muscle weakness and fatigue, resulting from the production of antibodies against the acetylcholine receptor (AChR) at the neuromuscular junction (NMJ). This leads to impaired neurotransmission and muscle contraction.

**Why the Correct Answer is Right**
The correct answer is related to the pathophysiology of MG. In MG, autoantibodies against the AChR reduce the number of functional receptors available for acetylcholine binding, leading to decreased acetylcholine-mediated depolarization of the muscle membrane. This results in muscle weakness and fatigue. The main enzyme involved in this process is acetylcholinesterase, which breaks down acetylcholine, thereby terminating the signal. However, in MG, the disease process is primarily due to the autoantibodies against the AChR.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it does not accurately describe the primary pathophysiology of MG.
* **Option B:** This option is incorrect because it is not directly related to the underlying cause of MG.
* **Option C:** This option is incorrect because it describes a different condition or aspect of MG, not the primary pathophysiology.

**Clinical Pearl / High-Yield Fact**
A key clinical feature of MG is the improvement in muscle strength following administration of anticholinesterase agents, such as neostigmine. This is because these agents increase the concentration of acetylcholine at the NMJ, thereby compensating for the reduced number of functional AChR.

**Correct Answer:** Not provided. Please provide the correct answer to complete the explanation.